FDA approves two new diabetes drugs
FDA has cleared two new drugs, insulin degludec injection (Tresiba—Novo Nordisk) and insulin degludec/insulin aspart injection (Ryzodeg 70/30—Novo Nordisk), for adults with diabetes. Insulin degludec injection, a long-acting insulin analog, was approved to improve glycemic control in adults with type 1 and type 2 diabetes. The drug is administered subcutaneously once a day. Insulin degludec/insulin …